The Value of Haematological Parameters and Tumour Markers in the Prediction of Intestinal Obstruction in 1474 Chinese Colorectal Cancer Patients

Abstract EN

Intestinal obstruction, a life-threatening problem, often occurs in patients with advanced colorectal cancer (CRC).

However, the cause of obstruction is still unknown.

Very few prediction models for intestinal obstruction in CRC exist, and their results are unreliable.

Therefore, we investigated whether preoperative serum tumour markers (STMs) combined with haematological and biochemical markers could be used as predictors.

We retrospectively analysed 1474 patients with CRC who underwent radical resection after admission.

Several clinical features, STMs, and serum biochemical and haematological indicators were analysed.

Predictors of intestinal obstruction were analysed with univariate and multivariate logistic regression.

The accuracy of the multivariate predictors of obstruction was measured by the area under the receiver operating characteristic (ROC) curve (AUC).

The Kaplan-Meier method was used to create survival curves.

Obstruction was found more in males (62.18%), never-smokers (73.95%), the left colon (54.20%), the tumour diameter>4.5 cm (55.88%), high differentiation (89.50%), and negative nerve invasion (70.17%).

The serum tumour markers (STMs) and peripheral blood routine indexes (PBRI) were significantly associated with obstructive status (p<0.05).

Multivariate analysis demonstrated that the neutrophil and lymphocyte counts, carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 125, albumin, alkaline phosphatase, gamma-glutamyl transpeptidase, total protein, and neutrophil-to-lymphocyte ratio were predictors of intestinal obstruction (p<0.05).

The AUC for the curve with all the eight factors was 0.715 (95% confidence interval: 0.673-0.758).

The STMs and PBRI were related to the obstruction status of the patients, and they could be used in combination with other clinical factors to significantly improve diagnosis and management of intestinal obstruction in CRC patients.